These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22608651)

  • 1. Anxiolytics.
    Sinclair LI; Nutt DJ
    Handb Clin Neurol; 2012; 106():669-79. PubMed ID: 22608651
    [No Abstract]   [Full Text] [Related]  

  • 2. Anxiolytic Effect of Cedrol on Behavior and Brain Neurotransmitter Levels of Female Mice.
    Zhang K; Yao L
    Biol Pharm Bull; 2019 Sep; 42(9):1575-1580. PubMed ID: 31257273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xiaochaihutang attenuates depressive/anxiety-like behaviors of social isolation-reared mice by regulating monoaminergic system, neurogenesis and BDNF expression.
    Ma J; Wang F; Yang J; Dong Y; Su G; Zhang K; Pan X; Ma P; Zhou T; Wu C
    J Ethnopharmacol; 2017 Aug; 208():94-104. PubMed ID: 28687505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of gidazepam on the level of monoamines in the brain of BALB/c mice].
    Lapitskaia AS; Kudrin VS; Blednov IuA
    Eksp Klin Farmakol; 1998; 61(4):12-3. PubMed ID: 9783099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a combination of duloxetine with hydroxyzine on experimental models of anxiety in mice.
    Patel S; Kale PP; Addepalli V; Sarkar A; Savai J
    Indian J Pharmacol; 2015; 47(2):173-6. PubMed ID: 25878376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation.
    McEwen BS; Chattarji S; Diamond DM; Jay TM; Reagan LP; Svenningsson P; Fuchs E
    Mol Psychiatry; 2010 Mar; 15(3):237-49. PubMed ID: 19704408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of novel anxiolytic 4-butyl-alpha-agarofuran on levels of monoamine neurotransmitters in rats.
    Zhang Y; Wang W; Zhang J
    Eur J Pharmacol; 2004 Nov; 504(1-2):39-44. PubMed ID: 15507219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stress-induced anxiety and endogenous anxiogenic substances].
    Hata T; Itoh E; Nishikawa H
    Nihon Yakurigaku Zasshi; 2000 Jan; 115(1):13-20. PubMed ID: 10876811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Easing the burden: treating refractory anxiety.
    Gorman JM
    CNS Spectr; 2004 Oct; 9(10):708. PubMed ID: 15448581
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical differences between anxiolytics and sedatives.
    Villeneuve A
    Mod Probl Pharmacopsychiatry; 1979; 14():1-12. PubMed ID: 33326
    [No Abstract]   [Full Text] [Related]  

  • 11. GABA
    Doron R; Sever A; Handelsman A; Toledano R; Franko M; Hirshler Y; Shamir A; Burstein O; Rehavi M
    J Mol Neurosci; 2018 May; 65(1):110-117. PubMed ID: 29737465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Ocimumoside A and B as anti-stress agents: modulation of brain monoamines and antioxidant systems in chronic unpredictable stress model in rats.
    Ahmad A; Rasheed N; Gupta P; Singh S; Siripurapu KB; Ashraf GM; Kumar R; Chand K; Maurya R; Banu N; Al-Sheeha M; Palit G
    Phytomedicine; 2012 May; 19(7):639-47. PubMed ID: 22455995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the binding capacity of the benzodiazepine site of gabaa receptor in mice C57BL/6 and BALB/C pretreated with anxiolytics].
    Iarkova MA
    Eksp Klin Farmakol; 2011; 74(8):3-7. PubMed ID: 22232906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational Studies in the Complex Role of Neurotransmitter Systems in Anxiety and Anxiety Disorders.
    Olivier JDA; Olivier B
    Adv Exp Med Biol; 2020; 1191():121-140. PubMed ID: 32002926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The peripheral and central role of the catecholamines in the mechanisms of anxiety.
    Lader M
    Int Pharmacopsychiatry; 1974; 9(3):125-37. PubMed ID: 4154319
    [No Abstract]   [Full Text] [Related]  

  • 16. [The neurochemical profile of the caudate nucleus in the anxiolytic action of benzodiazepine and nonbenzodiazepine tranquilizers on different models of anxiety].
    Talalaenko AN; Gordienko DV; Markova OP
    Eksp Klin Farmakol; 2000; 63(1):14-8. PubMed ID: 10763103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of (-)-Sesamin on Chronic Stress-Induced Anxiety Disorders in Mice.
    Zhao TT; Shin KS; Park HJ; Yi BR; Lee KE; Lee MK
    Neurochem Res; 2017 Apr; 42(4):1123-1129. PubMed ID: 27995494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabotropic glutamate receptors: potential drug targets for the treatment of anxiety disorders?
    Pitsikas N
    Eur J Pharmacol; 2014 Jan; 723():181-4. PubMed ID: 24361306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of persistent anxiety and novel uses for anxiolytics.
    J Clin Psychiatry; 1996; 57 Suppl 7():3-95. PubMed ID: 8690695
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anxiety and the mechanisms of action of anxiolytics].
    Marino A; Costa R
    Recenti Prog Med; 1993 Feb; 84(2):129-41. PubMed ID: 8096650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.